Following on an April comment letter, fifty-five LEAD Coalition member organizations and supporters wrote again in early August encouraging the Centers for Medicare and Medicaid Services (CMS) to issue a National Coverage Decision allowing PET amyloid imaging in the evaluation of progressive cognitive decline under the narrowly defined circumstances of the appropriate use criteria (AUC) […]
LEAD Coalition Strengthens Call for CMS to Approve PET Amyloid Imaging





